BEAM Earnings

Quarterly EPS
$-1.17
Q3 2024
$-1.09
Q4 2024
$-1.23
Q1 2025
$-1.00
Q2 2025
$-1.10
Q3 2025
$2.37
Q4 2025
$-0.91
Q1 2026
$-1.18
Q2 2026
Latest Revenue490.0K
Latest Net Income-122678000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.18490.0K-122678000-94.2%-18.0%
Q1 2026-$0.9131.7M-94318000+324.9%+26.0%
Q4 2025$2.37114.1M244.3M+279.5%+317.4%
Q3 2025-$1.109.7M-112728000-32.0%+6.0%
Q2 2025-$1.008.5M-102138000-28.1%+9.9%
Q1 2025-$1.237.5M-108330000+0.8%-1.7%
Q4 2024-$1.0930.1M-90354000-90.5%-161.9%
Q3 2024-$1.1714.3M-96668000-17.0%+4.1%
Q2 2024-$1.1111.8M-91051000
Q1 2024-$1.217.4M-98669000
Q4 2023$1.76316.2M142.8M
Q3 2023-$1.2217.2M-96088000
Beam Therapeutics (BEAM) — Earnings